Bio-Rad Laboratories BIO
NYSE BIO
$369.17 +13.67 (+3.85%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bio-Rad Laboratories (BIO) Gains from Sales and Divestitures (2020)

Updated

Bio-Rad Laboratories (BIO) posted Gains from Sales and Divestitures of $11.7 million for Q2 2020.

Analysis

Bio-Rad Laboratories (BIO) Gains from Sales and Divestitures (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Bio-Rad Laboratories 9.87 Bn 3.73 Bn 345.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 11.70 Mn
API Access

Bio-Rad Laboratories Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BIO&period=max&api_key=YOUR_API_KEY